CONTRAVE

Product NDC
64764-890
11-digit product format
647640890
Labeler code
64764
Product ID
64764-890_ed2da3a6-0614-4bea-8e82-962cbaae6428
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
naltrexone hydrochloride and bupropion hydrochloride
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Labeler
Takeda Pharmaceuticals America, Inc.
Application
NDA200063
Marketing category
NDA
Marketing start
2014-09-10
Marketing end
0000-00-00
Substance
NALTREXONE HYDROCHLORIDE; BUPROPION HYDROCHLORIDE
Active strength
8 mg/1; mg/1
Pharmacologic classes
Opioid Antagonist [EPC],Opioid Antagonists [MoA],Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]
NDC exclude flag
E
Listing certified through
2018-12-31
Current FDA listing
Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
64764-890-99EA - Each64764-890c28c0e0c-4bae-4e46-b3a7-55008a061f6012014-10-03